Comparison of bretylium tosylate and lidocaine in management of out of hospital ventricular fibrillation: a randomized clinical trial.

[1]  B. Pitt,et al.  Kinetics of antifibrillatory effects of bretylium: correlation with myocardial drug concentrations. , 1980, The American journal of cardiology.

[2]  A. M. Goldman,et al.  Bretylium tosylate in the management of recurrent ventricular fibrillation complicating acute myocardial infarction. , 1980, Heart & lung : the journal of critical care.

[3]  R. Cardinal,et al.  Electrophysiological effects of bretylium tosylate on subendocardial Purkinje fibers from infarcted canine hearts. , 1978, The Journal of pharmacology and experimental therapeutics.

[4]  E. Fallen,et al.  Experience with Bretylium Tosylate By a Hospital Cardiac Arrest Team , 1977, Circulation.

[5]  L. Cobb,et al.  Recurrent ventricular fibrillation and modes of death in survivors of out-of-hospital ventricular fibrillation. , 1975, The New England journal of medicine.

[6]  R. Arcidiacono,et al.  Chemical ventricular defibrillation of the human heart with bretylium tosylate. , 1973, The American journal of cardiology.

[7]  W. Parmley,et al.  Cardiovascular effects of bretylium tosylate in acute myocardial infarction. , 1973, JAMA.

[8]  R. Langendorf,et al.  Response of Resistant Ventricular Tachycardia to Bretylium: Relation to Site of Ectopic Focus and Location of Myocardial Disease , 1973, Circulation.

[9]  K. Hammermeister,et al.  The comparative inotropic effects of six clinically used antiarrhythmic agents. , 1972, American heart journal.

[10]  J. Koch-weser,et al.  Effectiveness of Bretylium Tosylate against Refractory Ventricular Arrhythmias , 1972, Circulation.

[11]  N. Fowler,et al.  Evaluation of Bretylium Tosylate for the Treatment of Premature Ventricular Contractions , 1972, Circulation.

[12]  S. Teasdale,et al.  Bretylium tosylate in the management of refractory ventricular fibrillation. , 1971, Canadian Medical Association journal.

[13]  J. Markis,et al.  Characteristics and mechanism of inotropic and chronotropic actions of bretylium tosylate. , 1971, The Journal of pharmacology and experimental therapeutics.

[14]  M. Bacaner,et al.  Use of bretylium tosylate in the management of acute myocardial infarction. , 1971, The American journal of cardiology.

[15]  J. Bigger,et al.  The effect of bretylium tosylate on the electrophysiologic properties of ventricular muscle and Purkinje fibers. , 1971, The American journal of cardiology.

[16]  A. Damato,et al.  Electrophysiologic effects of bretylium tosylate on single fibers of the canine specialized conducting system and ventricle. , 1970, The Journal of pharmacology and experimental therapeutics.

[17]  J. Stoker,et al.  Bretylium tosylate in prevention of cardiac dysrhythmias after myocardial infarction , 1970, British heart journal.

[18]  A. Doig,et al.  Bretylium tosylate in treatment of refractory ventricular arrhythmias complicating myocardial infarction. , 1970, British heart journal.

[19]  D. Schreinemachers,et al.  Effect of bretylium tosylate on ventricular fibrillation threshold. , 1969, Archives of Internal Medicine.

[20]  M. Bacaner,et al.  Bretylium Tosylate for Suppression of Ventricular Fibrillation after Experimental Myocardial Infarction , 1968, Nature.

[21]  M. Bacaner.  Quantitative comparison of bretylium with other antifibrillatory drugs , 1968 .

[22]  M. Bacaner.  Treatment of ventricular fibrillation and other acute arrhythmias with bretylium tosylate. , 1968, The American journal of cardiology.

[23]  M. Bacaner.  Bretylium tosylate for suppression of induced ventricular fibrillation. , 1966, The American journal of cardiology.

[24]  E. Braunwald,et al.  Analysis of the Acute Circulatory Effects of Guanethidine and Bretylium , 1962, Circulation research.